Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?"
Not Applicable
- Conditions
- chronic heart failure with type 2 diabetis mellitus
- Registration Number
- JPRN-UMIN000031563
- Lead Sponsor
- Osaka Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. End stage renal failure including eGFR<15ml/min/1.73m2 or dialytic therapy 2. Treated with SGLT2 inhibitor 3. Contraindications of SGLT2 inhibitor 4. Type 1 diabetes mellitus 5. The pregnant, breast feeder 6. BMI<18.5kg/m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the change of BNP at 6 months from baseline
- Secondary Outcome Measures
Name Time Method 1.Vital signs 2.Labolatory data: blood and urinary biomarkers 3.Cardiac function 4.Cardiac vascular event